Mettler-Toledo International Inc.
—- Market cap
- —
- Debt
- +$2.15B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MTD stock price vs WAT: inconclusive — current versus $1.57K implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WAT's multiple
Implied fair value · at MTD's multiple
Needs MTD P/E.
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 97% equity / 3% debt · EV / Revenue 12.73x · EV proxy / EBITDA proxy 39.93x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Mettler-Toledo International Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Waters Corporation · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MTD can sustain its strong margin profile while reaccelerating growth closer to WAT’s 7.0% pace, then MTD looks attractive to own because it is cheaper than WAT on P/E, P/S, EV/EBITDA, and EV/Revenue while still delivering stronger profitability.
MTD trades at a meaningful discount to WAT on both earnings and sales-based valuation, with 31.1x P/E versus 35.3x and 6.9x P/S versus 11.8x. The current price of $1308.47 sits below the implied P/E value of $1482.42, suggesting about 13.3% upside on that basis.
Supporting Metrics